Reimagining the landscape of therapeutic innovation, pharmaceutical biotechnology & drug discovery leverages molecular biology, genomics, and cell culture systems to create next-generation biopharmaceuticals. Monoclonal antibodies, recombinant proteins, and RNA-based therapies are now pivotal in treating complex diseases, including cancer and autoimmune disorders. High-throughput screening, structure-based drug design, and bioinformatics platforms expedite the identification of potent drug candidates. In Pharmaceutical Biotechnology & Drug Discovery, personalized medicine is also gaining traction through biomarkers and companion diagnostics, enabling tailored treatments. Furthermore, biotechnology enhances drug delivery via nanocarriers and controlled-release systems, improving efficacy and patient compliance. This evolving field plays a central role in shaping modern healthcare, offering precision, safety, and scalability in therapeutic development.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Phage Display-Based Biosensing for Rapid Detection of Neonatal Group B Streptococcal (GBS) Infection
Md Monir Hossain, RMIT University, Australia
Title : Contribution of bioengineered food in addressing hunger and food and nutrition security (FNS)
Santosh Kumar Mishra , S.N.D.T. Women's University (Retired), India
Title : An insight into sustainable practices in Environmental Biotechnology (EB)
Santosh Kumar Mishra , S.N.D.T. Women's University (Retired), India
Title : Lignocellulosic biomass to biofuels and biochemicals: Microbial innovations for a sustainable future
Gunjan Mukherjee, Chandigarh University, India